Application of Micellar Mobile Phase for Quantification of Sulfonamides in Medicated Feeds by HPLC-DAD

Rapid chromatographic procedure for quantification of five sulfonamides in medicated feeds are proposed. Satisfactory separation of sulfonamides from medicated feeds was achieved using a Zorbax Eclipse XDB C18 column (4.6 × 150 mm, 5 µm particle size) with a micellar mobile phase consisting of 0.05 M sodium dodecyl sulphate, 0.02 M phosphate buffer, and 6% propan-2-ol (pH 3). UV quantitation was set at 260 nm. The proposed procedure allows the determination of sulfaguanidine, sulfadiazine, sulfamerazine, sulfamethazine, and sulfamethoxazole in medicated feeds for pigs and poultry. Application of the proposed method to the analysis of five pharmaceuticals gave recoveries between 72.7% to 94.7% and coefficients of variations for repeatability and reproducibility between 2.9% to 9.8% respectively, in the range of 200 to 2000 mg/kg sulfonamides in feeds. Limit of detection and limit of quantification were 32.7–56.3 and 54.8–98.4 mg/kg, respectively, depending on the analyte. The proposed procedure for the quantification of sulfonamides is simple, rapid, sensitive, free from interferences and suitable for the routine control of feeds. In the world literature, we did not find the described method of quantitative determination of sulfonamides in medicated feeds with the use of micellar liquid chromatography.     

磁性反相限进材料的制备及其应用

以磁性二氧化硅（Fe₂O₃@SiO₂）为基质,利用表面原子转移自由基聚合技术（SI-ATRP）,在改性后的Fe₂O₃@SiO₂内表面接枝甲基丙烯酸十八烷基酯（SMA）、外表面接枝甲基丙烯酸缩甘油酯（GMA）,酸解后得到磁性反相限进材料Fe₂O₃@SiO₂-SMA-GMMA,并通过扫描电镜（SEM）、X射线衍射（XRD）、透射电镜（TEM）、振动样品磁强计（VSM）和元素分析对其进行表征。研究表明,Fe₂O₃@SiO₂-SMA-GMMA对牛血清白蛋白（BSA）的排阻能力为90.4%;对磺胺异恶唑（SIZ）、磺胺二甲氧基嘧啶（SDM）、甲氧苄啶（TMP）和磺胺甲基嘧啶（SMR）的最大吸附量分别为2.76、2.24、1.51和1.34 mg/g。Fe₂O₃@SiO₂-SMA-GMMA应用于牛奶和牛血清样品中SIZ、SMR和SDM的分离富集,SIZ、SMR和SDM的加标回收率为88.7%~90.8%,相对标准偏差为3.3%~5.3%。磁性反相限进材料可简化生物基质样品的前处理过程,对血液样品或食品样品等领域的分析检测具有重要价值。     

The Shapes of Sulfonamides: A Rotational Spectroscopy Study

Benzenesulfonamides are a class of molecules of extreme interest in the biochemical field because many of them are active against a variety of diseases. In this work, the pharmacophoric group benzensulfonamide, its derivatives para-toluensulfonamide and ortho-toluensulfonamide, and the bioactive molecule sulfanilamide, were investigated using rotational spectroscopy to determine their conformations and the influence of different substituents on their structures. For all species, the hyperfine structure due to the ¹⁴N atom was analyzed, and this provided crucial information for the unambiguous identification of the observed conformation of all molecules. In addition, for ortho-toluensulfonamide, the vibration–rotation hyperfine structure related to the methyl torsion was analyzed, and the methyl group rotation barrier was determined. For benzensulfonamide, partial r_S and r₀ structures were established from the experimental rotational constants of the parent and two deuterated isotopic species. In all compounds except ortho-toluensulfonamide, the amino group of the sulfonamide group lies perpendicular to the benzene plane with the aminic hydrogens eclipsing the oxygen atoms. In ortho-toluensulfonamide, where weak attractive interactions occur between the nitrogen lone pair and the methyl hydrogen atoms, the amino group lies in a gauche orientation, retaining the eclipsed configuration with respect to the SO₂ frame. A comparison of the geometrical arrangements found in the PDB database allowed us to understand that the bioactive conformations are different from those found in isolated conditions. The conformations within the receptor are reached with an energy cost, which is balanced by the interactions established in the receptor.     

Crystal structure of 3‐hydroxy methyl 4,6‐dimethoxy‐9‐phenylsulfonyl‐carbazole

The crystal structure of 3‐Hydroxy methyl 4,6‐dimethoxy‐9‐phenylsulfonyl‐carbazole. (C₂₁H₁₉NO₅S) has been determined [CCDC 194425]. The compound crystallizes from methanol in the monoclinic system, space group I2/c, with unit cell parameters: a = 20.498(2), b = 9.258(2), c = 21.866(3)Å, β = 116.450(10)°, Z = 8, V = 3715.2(10)ų. The crystal structure was solved by direct methods and refined by full‐matrix least squares to a final R‐value of 0.050 with 3508 unique reflections. The planar carbazole ring fragment is inclined at an angle of 79.9(1)° to the phenylsulfonyl group. The sum of the angle about N is 351.6(2)°. The atoms linked to the central hexavalent S atom are arranged in a tetrahedral configuration with the larger deviations in the O‐SO angles [O1‐S‐O2 = 119.7(2)°] and the O1‐S‐N and O2‐S‐N angles [106.1(2) and 106.9(1)°, respectively].     

Synthesis of {CB11} Monocarborane Sulfonamides by B2-Selective Rhodium-Catalyzed B−H Activation

The synthesis of monocarborane sulfonamides is reported. The methodology relies on coupling of the anionic {CB₁₁} boron cluster to sulfonyl azides. Under rhodium catalysis and with the assistance of a pyridine or pyrimidine directing group at the C1 position, the cluster undergoes B−H activation. Conditions have been identified that lead to B2-selective mono-sulfonamidation with concomitant loss of N₂. The protocol requires no additional ligand, oxidant or base and enables B−N bond formation with various monocarborane and sulfonyl azide inputs. The new products possess the structure [1-(heteroaryl)-2-(NHSO₂Ar)−CB₁₁H₁₀]⁻ and have been fully characterized by NMR spectroscopy and mass spectrometry. In addition, three solid state structures confirm the particular B2 substitution pattern. Furthermore, the stoichiometric reaction of the pyridinyl monocarborane precursor with Rh(III) affords a cyclometalated complex with a direct B−Rh bond that has also been characterized by X-ray crystallography.     

Novel sulfonamide-functionalized arylidene indolones as potent α-glucosidase inhibitors: Synthesis,characterization, and in vitro and in silico studies

3-Arylidene-1-(2,6-dichlorophenyl)indolones and in particular their 5-methylaminosulfonyl derivatives efficiently inhibit α-glucosidase enzyme. The results are corroborated by in silico docking studies which show the binding of aminosulfonyl derivatives to be more favorable due to additional hydrogen bonding. The most active compound of the series shows the IC₅₀ of 6.19 μm.